Zivo Bioscience, Inc.·4

Oct 25, 7:07 PM ET

PAYNE JOHN BERNARD 4

4 · Zivo Bioscience, Inc. · Filed Oct 25, 2021

Insider Transaction Report

Form 4
Period: 2021-10-21
PAYNE JOHN BERNARD
DirectorPresident and CEO
Transactions
  • Award

    Nonstatutory Stock Option to Purchase Common Stock

    2021-10-21+192,000192,000 total
    Exercise: $5.50Exp: 2031-10-20Common Stock (192,000 underlying)
Footnotes (1)
  • [F1]The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% upon acceptance of the grant, 25% on each of the next two 4-month anniversaries of the grant, and 25% on the day prior to the Company's 2022 Annual Meeting of Stockholders.

Documents

1 file
  • 4
    section16.xmlPrimary

    PRIMARY DOCUMENT